Home › Type 2 Diabetes › Washington › Kirkland
Type 2 Diabetes clinical trials in Kirkland, WA
4 studies for Type 2 Diabetes are looking for participants at sites in and around Kirkland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
RecruitingPhase 3
- ERA Health Research - Redmond, Redmond · 4 mi away
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RecruitingPhase 3
- Era Health Research, Redmond · 4 mi away
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
RecruitingPhase 2
- Eastside Research Associates, Redmond · 4 mi away
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Redmond · 4 mi away
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL24 studies
- Boston, MA20 studies
- Miami, FL19 studies
- Chicago, IL19 studies
- Dallas, TX19 studies
- Columbus, OH18 studies
- Las Vegas, NV18 studies
- Atlanta, GA17 studies
- San Diego, CA17 studies
- Los Angeles, CA16 studies
Other studies in Kirkland
- Non-Small Cell Lung Cancer11 studies
- Parkinson's Disease8 studies
- Lung Cancer8 studies
- Breast Cancer7 studies
- Colorectal Cancer7 studies
- Metastatic Cancer6 studies
- Acute Myeloid Leukemia6 studies
- Prostate Cancer5 studies
- Melanoma5 studies
- Ovarian Cancer5 studies
- Obesity4 studies
- Overweight4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.